About Us

OMNI Oncology’s mission is to support community oncology with strategically targeted informational interactive programs and virtual tumor boards. Programs and their slides are available on demand and distributed in our newsletters to enhance reach and provide an archival resource for continued access. OMNI Programs have been engaging community oncologists to raise awareness about developments in precision medicines in Oncology and MRD monitoring with great success since 2019.

For inquiries, please contact Charles Weaver, MD, chweaver@omnihealthmedia.com

Omni Oncology Programs

Case-Based Discussion Series

The objective of the Case Based Discussion programs are to raise awareness among community oncologists about changes in cancer care and gain strategic insights through their interaction with a leading KOL Oncologist Moderator, and peer to peer discussions.  

The programs are virtual interactive programs that bring a leading KOL together with targeted physicians based on clinic, geography, NGS tests results or other parameters. Each program consists of a group of 8-12 oncologists and is conducted digitally via Zoom. The Zoom format allows for better attendance, access to difficult to reach physicians, and is recorded for sponsor viewing and insight gathering.  OMNI currently hosts over 800 PSI programs annually with leading KOLs. We specialize in targeted recruitment-reaching the “hard to reach” physician.

Virtual Tumor Boards

Weekly virtual tumor boards are focused on solid tumors as well as molecular testing to engage community oncologists with both didactic educational updates and clinical case discussions. Our weekly virtual tumor boards currently feature:

The objective of the OMNI virtual tumor boards is to provide a forum where
community oncologists can access key opinion leaders to discuss new data and clinical cases with the goal of improving patient care and enhancing access to appropriate molecular testing and precision medicine use.

  • Raise awareness of targeted treatment options.
  • Help with difficulties in interpreting genomic data.
  • Provide clinical decision support regarding the role of MRD assessment.
  • Introduce new molecular tests, testing, and interpretations.
  • Overcome inherent barriers in rural and underserved communities.

Webinars

OMNI Oncology produces MD authored Webinars for patients and oncology care providers. Webinars are available on demand at OMNIOncology.net and targeted, in box distribution to the OMNI Oncology professional network of engaged community oncologists.

Hard to reach community medical oncologists are the primary audience for OMNI programs. Other oncology focused programs designed to reach urologists, gynecologic oncologists, and throracic surgery are also available. OMNI Oncology’s US reach is validated against the NPI database to confirm physicians and other HCPs.

Patient Webinars: The CancerConnect platform was founded in 1997 and has reached over 50 million patients since inception. We develop Webinars and content in a variety of formats from “Ask The Expert” to tutorials.  Patient webinars are distributed on CancerConnect and on other strategic web destinations as well as through our monthly patient newsletter and social community. Recent examples of patient webinars include the following:

“Expert to In-Box” Conference Coverage 

Omni Conference Coverage consists of a single topic content program that highlights recent practice changing data from medical conferences authored by leading Key Opinion Leaders (KOL) specifically for community oncologists. Single topic coverage is designed to provide a focused overview of “practice shaping” data in context. Specific program objectives are determined prior to program implementation. Digital “in box” distribution to ~ 3500 community oncologists weekly for 3 weeks post conference via the OMNI Oncology Newsletters and posting on OMNIOncology.Net

Newsletters

Dynamic, weekly oncology newsletters are are expertly curated publications delivering timely updates on the latest advances in cancer care and research—ensuring your innovations reach clinicians making decisions at the point of care. Each issue spotlights actionable opportunities for oncologists to connect directly with leading key opinion leaders, participate in educational forums, and remain at the forefront of emerging therapies and clinical best practices.

Partner with us to position your breakthroughs and educational initiatives where they’ll have maximum impact—with the practitioners shaping the future of oncology in the community setting.

Chief Executive Officer: Charles H. Weaver, MD

Charles Weaver, MD, is a pioneering stem cell cancer researcher, developer of the modern practice management industry, strategic oncology consultant, and early advocate and adopter of digital media and social media solutions to enhance community oncology and patient care.

Dr. Weaver is the CEO and Founder of OMNI Oncology, an early “virtual” digital media company focused on educating community oncologists and empowering patients through internet-based cancer information to seek optimal cancer care, which he has helmed for over 25 years. In addition to education, OMNI provides strategic insights and consulting for clinical trial and drug development, social media solutions, and digital content distribution to a diverse group of clients in oncology including the pharma and medical device industries, hospitals, physician providers, and advocacy groups.

Prior to this, Dr. Weaver served as the Chief Medical Officer of a Physician Practice Management company and worked to transition stem cell therapies to the private sector, making these therapies more accessible and affordable for patients. He created one of the earliest national clinical trials research networks to perform pivotal clinical trials at community cancer programs, helped pioneer risk based managed care contracting, and developed cancer treatment strategies and educational programs used by over 750 oncologists in the U.S. He remains actively engaged in strategic consulting around all aspects of oncology and cancer care.

Dr. Weaver earned a Doctor of Medicine degree from the University of Washington and trained at the University of Pennsylvania, National Cancer Institute, and Fred Hutchinson Cancer Research Center. He has authored 75 articles in major medical journals including the New England Journal of Medicine, The Journal of Clinical Oncology, Blood, Cancer, Bone Marrow Transplantation and has lectured at over 100 universities and cancer centers such as the University of London, Stanford, Duke, and Georgetown.

Meg Monday -Medical Education Advocate

Meg Monday is a passionate leader in medical education, dedicated to advancing better outcomes for patients facing complex diseases. With over 25 years of experience, Meg has directed medical education teams through every phase of program development, from formative market research and public outreach to continuing medical education (CME). Her career began in science writing and was shaped by a foundation in mechanical engineering, fueling her analytical approach to addressing healthcare challenges through education.

Drawn by the potential to transform patient care via knowledge and engagement, Meg quickly focused her expertise on medical education. She has overseen initiatives across the educational spectrum, integrating research-driven strategies, compliance, and consumer learning to drive meaningful improvements in patient health.

Most recently, Meg served as Executive Director of Content Development at Medscape, where she led the US content team. In this role, she ensured global CME programs were not only evidence-based and compliant, but also produced measurable advances in patient outcomes. Her enduring commitment is to scientifically sound, impactful learning that empowers both practitioners and patients in the evolving landscape of healthcare.